Form 4: Assertio Holdings Director, Sigurd Kirk, Receives Stock Options and Restricted Stock Units

Director Sigurd Kirk received stock options and restricted stock units from Assertio Holdings following the company's annual meeting.

Summary

• Sigurd Kirk, a director of Assertio Holdings, Inc., received 53,750 restricted stock units and 81,225 stock options on May 23, 2024.
• The grants were made in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy following the 2024 Annual Meeting of Stockholders.
• The restricted stock units and stock options vest in three equal installments on May 23, 2025, 2026, and 2027, contingent upon continued service.
• The exercise price for the stock options is $1.01.
• The expiration date for the stock options is May 23, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of stock options and restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The vesting schedule of the restricted stock units and stock options extends to May 2027, indicating a long-term commitment from the director.

Industry Context

Granting stock options and restricted stock units to directors is a common practice to align their interests with those of shareholders and incentivize long-term performance.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units.
• The specific terms of the grants, such as vesting schedules and exercise prices, are typically benchmarked against peer companies in the pharmaceutical industry.
• Companies like Teva Pharmaceutical Industries Ltd. and Mylan N.V. (now Viatris) also utilize similar equity-based compensation strategies for their directors.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align director interests with long-term company performance.
• The grants do not have an immediate impact on employees, customers, suppliers, or creditors.

Key Dates